Genetic initiation, progression and prognostic markers in transitional cell carcinoma of the bladder: a summary of the structural and transcriptional changes, and the role of developmental genes.
Adshead
J M
JM
Department of Urology, Imperial College School of Medicine, Kennedy-Galton Centre, Northwick Park and St Mark's NHS Trust, Harrow, UK.
Kessling
A M
AM
Ogden
C W
CW
D017209:Apoptosis / Q000235:genetics; D014408:Biomarkers, Tumor / Q000235:genetics; D002295:Carcinoma, Transitional Cell / Q000235:genetics*; D002455:Cell Division / Q000235:genetics; D002869:Chromosome Aberrations; D002880:Chromosomes, Human, Pair 11 / Q000235:genetics; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics; D018450:Disease Progression; D005109:Extracellular Matrix / Q000235:genetics; D005784:Gene Amplification; D017353:Gene Deletion; D016161:Genes, Retinoblastoma / Q000235:genetics; D016158:Genes, p53 / Q000235:genetics; D006801:Humans; D019656:Loss of Heterozygosity; D009389:Neovascularization, Pathologic / Q000235:genetics; D011003:Ploidies; D011379:Prognosis; D014314:Trisomy; D001749:Urinary Bladder Neoplasms / Q000235:genetics*
D014408:Biomarkers, Tumor